Interim recommendations for use of recombinant COVID-19 vaccine updated to reflect latest evidence

The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.

For further information, see below:

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
High COVID-19 vaccine effectiveness in Israeli HCP